AcouSort AB (publ) (ACOU.ST)

SEK 11.5

(-0.86%)

Market Cap (In SEK)

171.39 Million

Revenue (In SEK)

10.55 Million

Net Income (In SEK)

-17.08 Million

Avg. Volume

18.36 Thousand

Currency
SEK
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
9.32-20.8
PE
-
EPS
-
Beta Value
0.691
ISIN
SE0009189608
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Torsten Freltoft
Employee Count
-
Website
https://www.acousort.com
Ipo Date
2020-12-14
Details
AcouSort AB (publ), a technology company, develops products and solutions for automated preparation of biological samples based on acoustofluidics technology for researchers and life science companies. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an integrated blood plasma separation module that enables in-line analysis of blood plasma from whole blood samples; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company was founded in 2010 and is based in Lund, Sweden.